TABLE 1.
Antibiotic susceptibility of E. coli and K. pneumoniae using Phoenix panel NMIC-300a
| Drug |
E. coli |
K. pneumoniae |
||
|---|---|---|---|---|
| MIC(s) (μg/ml) | Interpretation | MIC(s) (μg/ml) | Interpretation | |
| Ampicillin-sulbactam | 16, 8 | I | 16, 8 | S |
| Ampicillin | >16 | R | >16 | R |
| Aztreonam | ≤1 | S | ≤1 | S |
| Cefazolin | 4 | I | 2 | S |
| Cefepime | ≥0.5 | S | ≥0.5 | S |
| Cefoxitin | 16 | I | ≤4 | S |
| Ceftazidime | ≤0.5 | S | ≤0.5 | S |
| Ceftriaxone | ≤0.5 | S | ≤0.5 | S |
| Ertapenem | ≤0.125 | S | ≤0.125 | S |
| Gentamicin | ≤1 | S | 1 | S |
| Imipenem | ≤0.25 | S | ≤0.25 | S |
| Meropenem | ≤0.125 | S | ≤0.125 | S |
| Piperacillin-tazobactam | 8, 4 | S | 4, 4 | S |
| Tobramycin | 1 | S | ≤0.5 | S |
| Trimethoprim-sulfamethoxazole | ≤0.5, 9.5 | S | ≤0.5, 9.5 | S |
a
I, intermediate; R, resistant; S, susceptible.